Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double-blind, placebo-controlled study.

Farzin RezaeiBita MesgarpourAlireza JeddianAtefeh ZeionoddiniPayam MohammadinejadElaheh SalardiniMona ShahriariArefeh ZeinoddiniShahin Akhondzadeh

Published in: Human psychopharmacology (2017)

An 8-week course of treatment with cilostazol as an adjunct to risperidone showed a favorable safety and efficacy profile in patients with schizophrenia.

Keyphrases

double blind
placebo controlled
clinical trial
bipolar disorder
phase iii
open label
phase ii
depressive symptoms
randomized controlled trial
combination therapy
bone marrow